Literature DB >> 16542727

Sodium selenite induces apoptosis in cultured cortical neurons with special concomitant changes in expression of the apoptosis-related genes.

R Xiao1, Jian T Qiao, Hai F Zhao, J Liang, Huan L Yu, J Liu, Ai M Guo, W Wang.   

Abstract

Sodium selenite was used to examine whether selenium compound is able to trigger apoptotic degeneration in cultured cortical neurons in vitro and to explore the detailed changes in expression of the related genes during the apoptotic processes using molecular biological and flow cytometric examinations. The results indicated that: (1) cortical neurons treated with sodium selenite with different dosages (0.0008, 0.004, 0.0200, 0.1000, and 0.5000 microM) and different exposure times (2, 4, 24, and 48 h) exhibited dose- and time-dependent apoptotic processes as revealed by typical DNA ladder formation detected by agarose gel electrophoresis; (2) the internucleosomal DNA fragmentation detected by flow cytometric examination showed a prominent peak of hypodiploid DNA contents as early as 4h after exposure of 0.1 microM sodium selenite; (3) the DNA fragmentation induced by sodium selenite as revealed by the above two examinations could be blocked by aurintricarboxylic acid; (4) the transcriptions of mRNAs related to bcl-2, bax, c-fos, p53, and acetylcholinesterase (AChE) genes, as detected by RT-PCR assays, showed down-regulation for bcl-2 and up-regulation for bax, c-fos, p53, and AChE genes after exposure of sodium selenite. This study suggests that the sodium selenite is effective for inducing apoptosis in cultured cortical neurons and that relevant changes in expression of several apoptosis-related genes might further our understanding of the mechanism(s) that initiates and maintains the apoptotic processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542727     DOI: 10.1016/j.neuro.2006.01.008

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  7 in total

1.  Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.

Authors:  Marco Vinceti; Nikolay Solovyev; Jessica Mandrioli; Catherine M Crespi; Francesca Bonvicini; Elisa Arcolin; Eleni Georgoulopoulou; Bernhard Michalke
Journal:  Neurotoxicology       Date:  2013-05-31       Impact factor: 4.294

2.  Acetylcholinesterase involvement in apoptosis.

Authors:  Xue-Jun Zhang; David S Greenberg
Journal:  Front Mol Neurosci       Date:  2012-04-10       Impact factor: 5.639

3.  A case-control study of the risk of cutaneous melanoma associated with three selenium exposure indicators.

Authors:  Marco Vinceti; Catherine M Crespi; Carlotta Malagoli; Ilaria Bottecchi; Angela Ferrari; Sabina Sieri; Vittorio Krogh; Dorothea Alber; Margherita Bergomi; Stefania Seidenari; Giovanni Pellacani
Journal:  Tumori       Date:  2012 May-Jun

Review 4.  Role of acetylcholinesterase in lung cancer.

Authors:  Hui-Jun Xi; Ren-Pei Wu; Jing-Jing Liu; Ling-Juan Zhang; Zhao-Shen Li
Journal:  Thorac Cancer       Date:  2015-03-20       Impact factor: 3.500

Review 5.  Friend or foe? The current epidemiologic evidence on selenium and human cancer risk.

Authors:  Marco Vinceti; Catherine M Crespi; Carlotta Malagoli; Cinzia Del Giovane; Vittorio Krogh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2013       Impact factor: 3.781

6.  The effect of sodium selenite on apoptotic gene expression and development of in vitro cultured mouse oocytes in comparison with in vivo obtained oocytes.

Authors:  Maziar Malekzadeh Kebria; Mojdeh Salehnia; Saeed Zavareh; Seyyed Saeed Moazzeni
Journal:  Vet Res Forum       Date:  2020-12-15       Impact factor: 1.054

7.  Selenite stimulates mitochondrial biogenesis signaling and enhances mitochondrial functional performance in murine hippocampal neuronal cells.

Authors:  Natalia Mendelev; Suresh L Mehta; Haza Idris; Santosh Kumari; P Andy Li
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.